creators_name: Ugwuja, Emmanuel Ike
creators_name: Ugwu, Nicholas Chukwuka
creators_id: ugwuja@yahoo.com
creators_id: 
editors_name: Kakkilaya, Srinivas
editors_id: Kakkilaya BS
type: journale
datestamp: 2007-09-28 23:23:57
lastmod: 2011-03-11 08:56:58
metadata_visibility: show
title: Helicobacter pylori In Uninvestigated Dyspepsia In Primary Cares In Abakaliki, Nigeria
ispublished: pub
subjects: OJHAS
full_text_status: public
keywords: H. pylori, infection, Prevalence, Dyspepsia, Ulcer
abstract: There is paucity of information on the prevalence of Helicobacter pylori infection in Nigeria. Enzyme-linked immunosorbent assay (ELISA) was used to determine the prevalence of immunoglobulin G (IgG) antibodies to H. pylori in 262 consecutive patients (aged 5.5-56 years) presenting with dyspepsia in primary health cares in Abakaliki, Nigeria. Sixty-nine (26.3%) of the patients had IgG antibodies to H. pylori. Significantly higher prevalence of H. pylori was recorded in older patients than in those ≤ 20 years [29% vs11% (95%CI: 0.072-0.288%)]. Infection was comparable between males and females [28% vs 25%, (95% CI: - 0.078 – 0.138)] but inversely related to the socio-economic status of patients [30.5% vs 14%. (95% CI: 0.054-0.28) and 30.3% vs 8.3% (95% CI: 0.053-0.391) between lower and middle and between lower and upper class respectively]. The high endemicity of H. pylori infection in this study needs confirmation in different settings and/or in the general population.
date: 2007-07-17
date_type: published
publication: Online Journal of Health and Allied Sciences
volume: 6
number: 1
publisher: Dr. B.S. Kakkilaya
refereed: TRUE
referencetext: 1.	Calam J. Clinical science of Helicobacter pylori infection: ulcers and NSAIDs. Br. Med Bull 1998; 54: 55-62.
2.	Hooton C, Dempsey C, Keohane J et al. Helicobacter pylori: prevalence of antimicrobial resistance in clinical isolates. BJBS 2006;63(3):113-6.
3.	Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol. Rev 19(3):449-490.
4.	Rosenstock S, Kay L, Rosenstock C, et al. Relationship between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut 1997;41(2):169-76.
5.	McColl KEL, El-Nujumi A, Murray L et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997;40:302-6.
6.	McColl KEL, Gillen D, Dickson AS et al. Eradication of Helicobacter pylori in functional dyspepsia. BMJ 1999;319:451-451.
7.	Heaney A, Collins JSA, Watson RGP et al. A prospective randomised trial of a “test and treat” policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to hospital clinic. Gut 1999;45:186-90.
8.	Vaira D, Miglioli M, Mule P et al. Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut 1994;35:309-12.
9.	Parsonnet J. Helicobacter pylori. Infect Dis Clin North Am. 1998;12(1):185-97.
10.	Yakoob J, Abid S, Jafri W et al.  Comparison of biopsy-based methods for the detection of Helicobacter pylori infection. BJBS 2006;63(4):159-162.
11.	Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000;22(2):283-97.
12.	Nijevitch AA, Scherbakov PL. Helicobacter pylori and gastrointestinal symptoms in school children in Russia. J Gastroenterol Hetatol 2004;19(5):490-6.
13.	Malaty HM, Logan ND, Graham DY et al. Helicobacter pylori infection in preschool and school-aged minority children: effect of socioeconomic indicators and breast-feeding practices. Clin Infect Dis. 2001;32(10):1387-92.
14.	Malaty HM, Haveman T, Graham DY et al. Helicobacter pylori infection in asymptomatic children: impact of epidemiologic factors on accuracy of diagnostic tests. J Pediatr Gastroenterol Nutr. 2002;35(1):59-63.
15.	Ertem D, Harmanci H, Pehlivanoglu E. Helicobacter pylori infection in Turkish preschool and school children: role of socioeconomic factors and breast-feeding. Turk J Pediatr. 2003;45(2):114-22.
16.	Kelly SM, Pitcher MC, Farmery SM et al. Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom. Gastroenterology 1994;107(6):1671-4.
17.	Holcombe C, Omotara BA, Eldridge J et al. H. pylori, the most common bacterial infection in Africa: a random serological study. Am J Gastroenterol. 1992;87(1):28-30.
18.	Pronovost AD, Rose SL, Pawlak JW et al. Evaluation of new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results. Journal of Clinical Microbiology 1994;32:46-50.
19.	McColl KEL, Murray LS, Gillen D et al.  Randomized trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. BMJ 2002;324:999.
20.	Jaakkimainen RL, Boyle E, Tudiver F. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. BMJ 1999;319:1040-1044.
21.	Crabtree JE, Shallcross TM, Heatley RV et al. Evaluation of commercial ELISA serodiagnosis of Helicobacter pylori infection. J Clin Path 1991;44:326-8.
22.	Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995;33(5):1203-5.
23.	Moayyedi P, Soo S, Deeks J et al, on behalf of the Dyspepsia Review Group. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. BMJ 2000;321:659-664.
24.	Blum AL, Arnold R, Stolte M et al. (The Frosch Study Group). Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. Gut 2000;47:473-480. 
25.	Tally NJ, Meineche-Schmidt V et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomised, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055-1065.
26.	McColl KEL, Murray L, El-Omar E et al. Symptomatic benefit from eradicating  Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998;339:1869-1874.
27.	Blum AL, Tally NJ, O’Morain C et al. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998;339:1875-1881.
28.	Kuipers EJ, Lundell L, Klinkenberg EC et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux oesophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-1022.
29.	Parsonnet J, Rodriguez L, Gelb AB et al. Helicobacter pylori and gastric lymphoma. N Engl J Med 1994;330:1267-1271.
30.	Wu JCY, Chan FKL, Ching JYL et al. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomized trial. Gut 2004;53:174-179.
31.	Forne M, Dominguez J, Fernandez-Banares F et al. Accuracy of an enzyme immunoassay for the detection of Helicobacter pylori in stool specimens in the diagnosis of infection and post-treatment check-up. Am J Gastroenterol. 2000;95(9):2200-5.
32.	Dickerson LM and King DE. Evaluation and Management of Nonulcer Dyspepsia. Am. Fam. Physician 2004;70:107-14.
33.	Ahmed N, Sechi LA. Helicobacter pylori and gastroduodenal pathology: new threats of the old friend. Ann Clin Microbiol Antimicrob 2005;4:1.
34.	Patel P, Mendall MA, Khulusi S et al. Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet 1994;324:1043-8.
35.	Thumshirn M, Camilleri M, Saslow SB et al. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999;44:55–64.
36.	Tack J, Piessevaux H, Coulie B et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346–52.
37.	Soo S, Forman D, Delaney BC et al. A systematic review of psychological therapies for nonulcer dyspepsia. Am J Gastroenterol 2004;99(9):1817-22.
38.	Malaty HM, Kim JG, Kim SD et al. Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. Am J Epidemiol. 1996;143(3):257-62.
39.	Nijevitch AA, Sataev VU, Vakhitov VA et al. Childhood peptic ulcer in the Ural area of Russia: clinical status and Helicobacter pylori-associated immune response. J Pediatr Gastroenterol Nutr. 2001;33(5):558-64.
40.	Bernstein CN, McKeown I, Embil JM et al.  Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population. Dig Dis Sci. 1999;44(4):668-74.
41.	Kivi M, Tindberg Y. Helicobacter pylori occurrence and transmission: a family affair? Scand J Infect Dis. 2006;38(6-7):407-17.
42.	Herrera AG. Helicobacter pylori and food products: a public health problem. Methods Mol Biol. 2004;268:297-301.
43.	Sherman PM. Appropriate strategies for testing and treating Helicobacter pylori in children: when and how? Am J Med. 2004;117 Suppl 5A:30S-35S.
44.	Vaira D, Holton J, Ricci C et al. Review article: the transmission of Helicobacter pylori from stomach to stomach. Aliment Pharmacol Ther. 2001;15 Suppl 1: 33-42.
45.	Cave DR. How is Helicobacter pylori transmitted? Gastroenterology. 1997;113(6 Suppl):S9-14.
46.	Woodward M, Morrison C, McColl K. An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 2000;53:175-181.
47.	Vaira D, Holton J, Menegatti M et al.  Routes of transmission of Helicobacter pylori infection. Ital J Gastroenterol Hepatol. 1998;30 Suppl 3: S279-85.
48.	Shaib Y, El-Serag HB. The Prevalence and Risk Factors of Functional Dyspepsia in a Multiethnic Population in the United States. Am J Gastroenterol 2004;99(11):2210-2216.
citation:   Ugwuja, Emmanuel Ike and Ugwu, Nicholas Chukwuka  (2007) Helicobacter pylori In Uninvestigated Dyspepsia In Primary Cares In Abakaliki, Nigeria.  [Journal (On-line/Unpaginated)]     
document_url: http://cogprints.org/5717/1/2007-1-4.pdf